Interacting Drugs |
Pneumococcal polysaccharide vaccine (23-valent) vs Immunosuppressants |
Security Level |
 |
Mechanism |
Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated). Exceptions: Cytarabine (Liposomal). |
Management |
Monitor therapy |
Pneumococcal polysaccharide vaccine (23-valent) vs Immunosuppressants
Post Review about Pneumococcal polysaccharide vaccine (23-valent) vs Immunosuppressants Click here to cancel reply.
Other Interactions of Immunosuppressants
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.